Mesenchymal stem cells recruited by castration-induced inflammation activation accelerate prostate cancer hormone resistance via chemokine ligand 5 secretion

BACKGROUND: Androgen deprivation (AD) as the first-line treatment for advanced prostate cancer (PCa) is insufficient for a long-term effect. Castration resistance remains the greatest obstacle in PCa clinical therapy. Mesenchymal stem cells (MSCs) can migrate into PCa tissues contributing to tumor p...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yang, Zhang, Qingyun, Ma, Chengzhong, Yang, Xue, Lin, Rui, Zhang, Hongxiang, Liu, Yan, Han, Zhipeng, Cheng, Jiwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158918/
https://www.ncbi.nlm.nih.gov/pubmed/30257726
http://dx.doi.org/10.1186/s13287-018-0989-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158918/
https://www.ncbi.nlm.nih.gov/pubmed/30257726
http://dx.doi.org/10.1186/s13287-018-0989-8

Ejemplares similares